Skip to main content

Dementia: Classification and Aspects of Treatment

  • Conference paper
Psychopharmacology: Current Trends

Part of the book series: Psychopharmacology Series ((PSYCHOPHARM,volume 5))

  • 118 Accesses

Abstract

The syndrome dementia is defined by evidence of a decline in memory, thinking, and emotional functions. In this article, dementia is delimited only by its symptoms; the etiology, the course, and the extensiveness of the disorder are not used as criteria of a dementia syndrome. In the descriptive diagnoses of dementia disorders, however, different aspects of the disorders are used. Descriptive diagnoses are (a) benign senile forgetfulness, (b) primary degenerative disorders, (c) secondary dementias, (d) cerebrovascular disorders with dementia, (e) reversible dementias, and (f) dementias with unknown etiology. Primary degenerative disorders include the subgroups (a) senile dementia of Alzheimer type (SDAT), (b) Alzheimer’s disease (AD), (c) Pick’s disease, and (d) Huntington’s chorea. The question whether SDAT and AD should be included in one group is discussed. Very interesting and stimulating treatment research is going on in the field of dementias. Although there has still been no real breakthrough, some results indicate that dementia symptoms may be influenced by treatment. At present, treatment strategies go along the following lines: (a) pharmacological treatment, (b) control of sleep apneas and circulatory disturbances, (c) brain tissue transplantation, and (d) psychotherapy and mental activation. The pharmacological manipulation of dementia disorders focuses on substituting failing neurotransmitter systems. The use of nootropic drugs and gangliosides is still at an experimental level. Findings of vitamin B12 deficiency in late-onset dementia make vitamin B12 substitution relevant. White matter disturbances such as incomplete infarctions are reported in brains from demented patients. Coincident findings of increased sleep apneas with severe hypoxemia make studies of circulatory disturbances of interest. Transplantation of brain tissue has already left the animal experimental level and been applied to patients with parkinsonism. In some investigations, it is shown that mental activation causes not only a mental improvement but also changes in cerebrospinal fluid indicating the stimulation of trophic factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adolfsson R, Gottfries CG, Oreland L, Wiberg Å, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034

    Article  PubMed  CAS  Google Scholar 

  • Branconnier RJ, Cole JO, Dessain EC, Spera KF, Ghazvinian S, DeVitt D (1983) The therapeutic efficacy of pramiracetam in Alzheimer’s disease: Preliminary observations. Psychophar- macol Bull 19: 276

    Google Scholar 

  • Bråne G (1986) Normal aging and dementia disorders — coping and crisis in the family. Prog Neuropsychopharmacol Biol Psychiatry 10: 287–295

    Article  PubMed  Google Scholar 

  • Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer’s disease. A clinico-pathological study. Arch Psychiatr Nervenkr 223: 15–33

    Article  PubMed  CAS  Google Scholar 

  • Carlsson A (1986) Neurotransmitters in old age and dementia. In: Hafner H, Moschel G, Sartorius N (eds) Mental health in the elderly: A review of the present state of research. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Gottfries CG (1983) Dementia. In: Hippius H, Winokur G (eds) Clinical psychopharmacology. Excerpta Medica, Amsterdam, pp 271–285 (Psychopharmacology, vol 1/2)

    Google Scholar 

  • Gottfries CG (1986) Nosological aspects of differential typology of dementia of Alzheimer type. In: Bergener M (ed) Dimensions in aging. Academic, London, pp 207–219

    Google Scholar 

  • Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernäs SE, Nordberg A, Oreland L, et al. (1983) Biochemical changes in dementia disorders of Alzheimer type ( AD/SDAT ). Neurobiol Aging 4: 261–271

    Article  PubMed  CAS  Google Scholar 

  • Gottfries CG, Karlsson I, Svennerholm L (1985) Senile dementia — A white matter disease? In: Gottfries CG (ed) Normal aging, Alzheimer’s disease and senile dementia. Aspects on etiology, pathogenesis, diagnosis and treatment. Éditions de L’Université de Bruxelles, Bruxelles, pp 111–118

    Google Scholar 

  • Itil TM, Menon GN, Bozak M, Songar A (1982) The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double-blind controlled study with piracetam). Drug Dev Res 2: 448

    Google Scholar 

  • Karlsson I, Widerlöv E, Melin EV, Nyth AL, Bràne GAM, Rybo E, Rehfeld JF, Bissette G, Nemeroff CB (1985) Changes of CSF neuropeptides after environmental stimulation in dementia. Nord Psykiatr Tidsskr [Suppl 11] 49: 75–81

    Article  Google Scholar 

  • Loew DM, van Deusen EB, Meier-Ruge W (1978) Effect on the central nervous system. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 421–531 (Handbook of experimental pharmacology, vol 49 )

    Google Scholar 

  • Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type. Evidence of subgroups. Neurology (NY) 35: 453–461

    CAS  Google Scholar 

  • Nyberg P, Nordberg A, Wester P, Winblad B (1983) Dopaminergic deficiency is more pronounced in putamen than in nucleus candatus in Parkinson’s disease. Neurochem Pathol 1: 193–202

    Article  CAS  Google Scholar 

  • Pearce J (1974) Mental changes in parkinsonism (letter). Br Med J 1: 445

    Article  Google Scholar 

  • Regland B, Gottfries CG, Oreland L, Svennerholm L (1988) Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study. Acta Psychiatr Scand (Accepted for publication)

    Google Scholar 

  • Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer’s disease. Br Med J 288: 961–964

    Article  CAS  Google Scholar 

  • Sjögren T, Sjögren H, Lindgren AGH (1952) Morbus Alzheimer and morbus Pick. A genetic clinical and patho-anatomical study. Acta Psychiatr Neurol Sand [Suppl] 82

    Google Scholar 

  • Sourander P, Sjögren H (1970) The concept of Alzheimer’s disease and its clinical implications. In: Wolstenholme GEW, O’Connor M (eds) Alzheimer’s disease and related conditions. Churchill, London, pp 11–36

    Google Scholar 

  • Sourander L, Polo O, Alihanka J (1985) Sleep apnea and hypoxia in patients with senile dementia. Nordic Psychiatric Congress, 29 May-1 June

    Google Scholar 

  • Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315: 1241–1245

    Article  PubMed  CAS  Google Scholar 

  • Svennerholm L, Gottfries CG, Karlsson I (1987) Neurochemical changes in white matter of patients with Alzheimer’s disease. In: NATO Conference on multidisciplinary approach to myeline diseases. ( In press )

    Google Scholar 

  • Zawadski RT, Glazer GB, Lurie E (1978) Psychotropic drug use among institutionalized and non-institutionalized medicaid aged in California. J Gerontol 33: 825–834

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gottfries, C.G. (1988). Dementia: Classification and Aspects of Treatment. In: Casey, D.E., Christensen, A.V. (eds) Psychopharmacology: Current Trends. Psychopharmacology Series, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73280-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73280-5_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73282-9

  • Online ISBN: 978-3-642-73280-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics